The Fifty-third World Health Assembly,Having considered the report by the Director-General on HIV / AIDS;Noting with deep concern that nearly 34 million people worldwide are currently living withHIV / AIDS, and 95% are in developing countries; and that the development gains of the past 50 years,including the increase in child survival and in life expectancy, are being reversed by the HIV / AIDSepidemic;Further noting that in sub-Saharan Africa, whereover 23 million people are infected, HIV / AIDSis the leading cause of death, and where more women are now infected than men; and that HIVinfection is increasing rapidly in Asia, particularly in south and south-east Asia, where 6 millionpeople are infected;Recalling resolution WHA52.19 which inter alia requests the Director-General:to cooperate with Member States, at their request, and with international organizations inmonitoring and analysing the pharmaceutical and public health implications of relevantinternational agreements, including trade agreements, so that Member States can effectivelyassess and subsequently develop pharmaceutical and health policies and regulatory measuresthat address their concerns and priorities, and are able to maximize the positive and mitigatethe negative impact of those agreements;Recognizing that poverty and inequality between men and women are driving the epidemic; andthat denial, discrimination and stigma continue tobe major obstacles to an effective response to theepidemic;Underlining the need to advocate respect for human rights in the implementation of all measuresto respond to the epidemic;Acknowledging that political commitment is essential to deal with a problem of this magnitude;Recognizing that resources devoted to combating the epidemic both at national and internationallevels are not commensurate with the magnitude of the problem;Recalling United Nations Economic and Social Council resolution 1999 / 36 on humanimmunodeficiency virus / acquired immunodeficiency syndrome (HIV / AIDS), which stresses , interWHA53.142alia, governments responsibility to intensify all efforts in combating AIDS through multisectoralaction;Recalling the recent session of the United Nations Security Council devoted to the HIV / AIDScrisis in Africa, in which the Security Council recognized that HIV / AIDS is a unique modern-dayplague that threatens the political, economic and social stability of sub-Saharan Africa and Asia,1. URGES Member States:(1) to match their political commitment, as demonstrated in several recent initiatives ofpolitical leaders of Member States, to the magnitude of the problem by allocating an appropriatenational and donor budget for HIV / AIDS prevention aswell as for care and support of theinfected and affected;(2) to establish programmes to combat poverty with the support of donors, implement themin a rigorous and transparent manner, and advocate: cancellation of debt in order to free resources for, inter alia , HIV / AIDS prevention andcare, as proposed by the G8 Summit at Cologne, improvement of the living conditions of populations, reduction of unemployment, improvement of the standard of public health;(3) to provide increased support for UNAIDS, and WHO as one of its cosponsors, in theirefforts against AIDS, including efforts in the context of the International Partnership againstAIDS in Africa;(4) to strengthen public education on HIV / AIDS and to pay particular attention to nationalstrategic plans directed at reducing the vulnerability of women, children and adolescents,bearing in mind that public education and national campaigns should place emphasis onprevention, on reducing discrimination and stigmatization, and on promoting healthyenvironments to prevent and alleviate AIDS problems;(5) to take all necessary measures to protect children infected and / or affected by HIV / AIDSfrom all forms of discrimination, stigma, abuse and neglect, in particular protecting their accessto health, education and social services;(6) to apply experiences and lessons learned and the growing body of scientific knowledgeregarding proven effective interventions for prevention and care in order to reduce the spread ofHIV / AIDS and to increase the quality and length of life of those infected;(7) to ensure that blood transfusion services do not constitute an HIV risk factor by ensuringthat all individuals have access to safe blood and blood products that are accessible andadequate to meet their needs, are obtained from voluntary, nonremunerated blood donors, aretransfused only when necessary, and are provided as part of a sustainable blood transfusionprogramme within the existing health care system;WHA53.143(8) to build and strengthen partnerships between health providers and the community,including nongovernmental organizations, in order to direct community resources towardsproven effective interventions;(9) to implement key strategies for HIV / AIDS prevention, in particular management ofsexually transmitted infections and promotion of safer sex, including by ensuring availability ofmale and female condoms;(10) to strengthen health systems that ensure adequate and skilled human resources, supplysystems and financing schemes in order to address the needs for HIV / AIDS care and prevention;(11) to take steps to reduce use of illicit substances and to protect injecting drug users andtheir sexual partners against HIV infection;(12) to increase access to, and quality of, care in order to improve quality of life, assure thedignity of the individual, and meet the medical and psychosocial needs of people living withHIV / AIDS, including treatment and prevention of HIV-related illnesses and provision of acontinuum of care, with efficient referral mechanisms between home, clinic, hospital andinstitution;(13) to reaffirm their commitment to previous resolutions on the revised drug strategy and toensure the necessary actions within their national drug policies to guarantee public healthinterests and equitable access to care, including medicines;(14) to make use of indicators developed by WHO to monitor progress;(15) to collaborate with the WHO Secretariat and other international agencies to regularlyupdate existing databases in order to provide Member States with information on prices ofessential drugs including HIV-related drugs;(16) to increase access to treatment and prophylaxis of HIV-related illnesses through measuressuch as ensuring the provision and affordability of drugs, including a reliable distribution anddelivery system; implementation of a strong generic drug policy; bulk purchasing; negotiationwith pharmaceutical companies; appropriate financing systems; and encouragement of localmanufacturing and import practices consistent with national laws and international agreementsacceded to;(17) to define and affirm their role and, where appropriate, engage in partnerships andsolidarity initiatives to make prophylactic and therapeutic drugs accessible, affordable andsafely and effectively used, whether intended for prevention of mother-to-child transmission,prevention and treatment of opportunistic diseases, or antiretroviral treatment for patients;(18) to establish or to expand counselling services and voluntary confidential HIV-testing inorder to encourage health-seeking behaviour and to act as an entry point for prevention andcare;(19) to continue research on the prevention of mother-to-child transmission of HIV and tointegrate interventions for it into primary health care, including reproductive health services, aspart of comprehensive care for HIV-infected pregnant women and postnatal follow-up for themand for their families, ensuring that such research is free from interests that might bias theresults and that commercial involvement should be clearly disclosed;WHA53.144(20) to promote research on behaviour change and cultural factors that influence sexualbehaviour;(21) to establish and strengthen monitoring and evaluation systems, including epidemiologicaland behavioural surveillance and assessment of the response of health systems to the epidemicsof HIV / AIDS and sexually transmitted infections, with the promotion of intercountrysubregional collaboration;2. REQUESTS the Director-General:(1) to continue strengthening the involvement of WHO, as a cosponsor of UNAIDS, in theUnited Nations system-wide response to HIV / AIDS, including at country level;(2) to develop a global health-sector strategy for responding to the epidemics of HIV / AIDSand sexually transmitted infections as part of the United Nations system s strategic plan forHIV / AIDS for 2001-2005, and to report on progress in development of the strategy to theExecutive Board at its 107th session;(3) to give priority in WHO s regular budget to the prevention and control of HIV / AIDS, andto engage the Organization as an active partner in the implementation of a transparent and jointresource mobilization strategy in support of the unified budget and work plan of the UNAIDSSecretariat and its cosponsors, and to actively encourage the donor community to increasesupport for regional and country-level interventions;(4) to further mobilize funds in support of national HIV / AIDS prevention and controlprogrammes and for care and support given through the home and community-levelprogrammes;(5) to further support the implementation of drug price monitoring systems in Member States,at their request, with a view to the promotion of equitable access to care, including essentialdrugs;(6) to strengthen Member States capacity for the implementation of drug monitoring systemsin order to better identify adverse reactions and misuse of drugs within health systems, thuspromoting a rational use of drugs;(7) to continue the development of methods and support for monitoring the pharmaceuticaland public health implications of trade agreements;(8) to involve WHO fully in the International Partnership against AIDS in Africa, aswell asother programmes against HIV / AIDS in other Member States, particularly at country level,within the context of national strategic plans;(9) to cooperate with Member States in organizing nationally coordinated blood-transfusionservices;(10) to collaborate with Member States in strengthening the capacity of health systems both torespond to the epidemics through integrated prevention of HIV / AIDS and sexually transmittedinfections and care for infected people and to promote health systems research to frame policyon health systems response to HIV / AIDS and sexually transmitted infections;WHA53.145(11) to advocate respect for human rights in the implementation of all measures responding tothe epidemic;(12) to intensify the support of national efforts against HIV / AIDS, aimed at providingassistance to children infected or affected by the epidemic, focusing particularly in the worst-hitregions of the world and where the epidemic is severely setting back national developmentgains;(13) to appeal to the international community, relevant United Nations agencies, donoragencies and programmes, and intergovernmental and nongovernmental organizations to alsogive importance to the treatment and rehabilitation of children infected with HIV / AIDS, toinvite them to consider further involving the private sector;(14) to ensure that WHO, together with the UNAIDS Secretariat and other interested UNAIDScosponsors, pursue proactively and effectively its dialogue with the pharmaceutical industry, inconjunction with Member States and associations of persons living with HIV / AIDS, to makeHIV / AIDS-related drugs increasingly accessible to developing countries through drugdevelopment, cost reduction, and strengthening of reliable distribution systems;(15) to reinforce, promote, and explore partnerships both to make HIV / AIDS-related drugsaccessible through affordable prices, appropriate financing systems, and effective health caresystems and to ensure that drugs are safely and effectively used;(16) to cooperate with governments, at their request, and other international organizations onpossible options under relevant international agreements, including trade agreements, toimprove access to HIV / AIDS-related drugs;(17) to promote, encourage and support research and development on: vaccines appropriate forstrains of HIV found in both developed and developing countries; diagnostic tools andantimicrobial drugs for other sexually transmitted infections; and treatment for HIV / AIDS,including traditional medicine;(18) to intensify efforts to prevent HIV and sexually transmitted infections in women,including promotion of research on and development of microbicides and affordable femalecondoms to provide women and girls with female-initiated protection methods;(19) to continue, in the context of efforts underway with UNICEF, UNFPA and the UNAIDSSecretariat, to provide technical support to Member States for implementation of strategies andprogrammes to prevent mother-to-child transmission of HIV, and to improve capacity forintersectoral collaboration;(20) to provide support to Member States for collecting and analysing information on theepidemics of HIV / AIDS and sexually transmitted infections, developing methodologies forbehavioural surveillance, and producing periodic updates;(21) to provide increased support to Member States for the prevention of HIV transmission ininjecting drug users in order to avoid an explosive spread of HIV / AIDS in that vulnerablepopulation;(22) to advocate for research on nutrition in relation to HIV / AIDS;WHA53.146(23) to advise Member States on the appropriate treatment regimen for HIV / AIDS and toadvise in collaboration with other relevant international organizations on the management, legaland regulatory issues to improve affordability and accessibility;(24) to appeal to bilateral and multilateral partners to simplify the procedures for the allocationof resources.Eighth plenary meeting, 20 May 2000A53 / VR / 8= = =